Physician profile
David Lavian
NPI 1770582967
$2,926.57
in general payments reported to CMS, 2019-2025
20 companies · $69.95 in 2025
The $69.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,613 · 2020: $125 · 2021: $26.65 · 2022: $394 · 2023: $621 · 2024: $77.06 · 2025: $69.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $532.96 | 2019-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $389.43 | 2019-2024 | Farxiga |
| Pfizer INC. | $373.77 | 2019 | |
| Lilly USA, LLC | $230.05 | 2022-2023 | Taltz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $225.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $195.78 | 2019-2025 | |
| Spr Therapeutics, INC | $149.54 | 2023 | Sprint Pns System |
| Depuy Synthes Sales INC. | $125.00 | 2019 | |
| Allergan, INC. | $123.73 | 2019 | |
| Kyowa Kirin, INC. | $123.46 | 2022 | |
| Abbvie INC. | $107.24 | 2022 | |
| Paragon 28, INC. | $64.87 | 2019 | |
| Hologic Sales and Service, LLC | $56.97 | 2023 | Thinprep 2000 Processor, Aptima |
| Grt US Holding, INC. | $54.77 | 2022 | |
| Kvk-Tech, INC. | $53.85 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $38.58 | 2024-2025 | Saxenda, Wegovy |
| Merck Sharp & Dohme LLC | $26.65 | 2021 | |
| Amarin Pharma, INC. | $23.07 | 2019 | |
| Astellas Pharma US INC | $16.32 | 2019 | |
| Exact Sciences Corporation | $15.53 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lavian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.